Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Massafra

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Urology Case Reports|October 26, 2020
Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancerMarco Massafra, Maria Ilenia Passalacqua, Giuseppe Lupo, et al.
Translational Lung Cancer Research|April 23, 2021
A narrative review of MET inhibitors in non-small cell lung cancer with <i>MET</i> exon 14 skipping mutationsMariacarmela Santarpia, Marco Massafra, Vittorio Gebbia, et al.
Biologics : Targets & Therapy|October 22, 2021
Immunotherapeutic Advances for NSCLCMarco Massafra, Maria Ilenia Passalacqua, Vittorio Gebbia, et al.
Frontiers in Oncology|February 21, 2022
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future PerspectiveMichele Prisciandaro, Maria Antista, Alessandra Raimondi, et al.
JCO Precision Oncology|May 11, 2022
Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based TherapyGiovanni Randon, Giulia Maddalena, Marco Maria Germani, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Urology Case Reports|October 26, 2020
Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancerMarco Massafra, Maria Ilenia Passalacqua, Giuseppe Lupo, et al.
Translational Lung Cancer Research|April 23, 2021
A narrative review of MET inhibitors in non-small cell lung cancer with <i>MET</i> exon 14 skipping mutationsMariacarmela Santarpia, Marco Massafra, Vittorio Gebbia, et al.
Biologics : Targets & Therapy|October 22, 2021
Immunotherapeutic Advances for NSCLCMarco Massafra, Maria Ilenia Passalacqua, Vittorio Gebbia, et al.
Frontiers in Oncology|February 21, 2022
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future PerspectiveMichele Prisciandaro, Maria Antista, Alessandra Raimondi, et al.
JCO Precision Oncology|May 11, 2022
Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based TherapyGiovanni Randon, Giulia Maddalena, Marco Maria Germani, et al.
Pageof 1